Yeah, NW Bio was on my watch list back then when I thought of them as an antibody company since I was keeping track of possible competition to Medarex, a MAB company, of which I had a major holding. So I was surprised initially, when I first started (re)following NWBO a couple of years ago that it was involved in dendritic cell technology. Ditto with Celldex that was spun out of MEDX which while still part of MEDX, the initial name for the company was going to be Keycell, which would have been aptly named for their 'Key in a cell' dendritic cell tech.
News 
Market Data 
Discover 
AI
